Global Choroidal Neovascularization Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Choroidal Neovascularization Drug

• 1.1 Definition of Choroidal Neovascularization Drug
• 1.2 Choroidal Neovascularization Drug Segment by Type
  • 1.2.1 Global Choroidal Neovascularization Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 AVMOC-001
  • 1.2.3 BB-3
  • 1.2.4 BBT-007
  • 1.2.5 DG-3
  • 1.2.6 Entolimod
  • 1.2.7 EWA-001
  • 1.2.8 Others
• 1.3 Choroidal Neovascularization Drug Segment by Applications
  • 1.3.1 Global Choroidal Neovascularization Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Global Choroidal Neovascularization Drug Overall Market
  • 1.4.1 Global Choroidal Neovascularization Drug Revenue (2014-2025)
  • 1.4.2 Global Choroidal Neovascularization Drug Production (2014-2025)
  • 1.4.3 North America Choroidal Neovascularization Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Choroidal Neovascularization Drug Status and Prospect (2014-2025)
  • 1.4.5 China Choroidal Neovascularization Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Choroidal Neovascularization Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Choroidal Neovascularization Drug Status and Prospect (2014-2025)
  • 1.4.8 India Choroidal Neovascularization Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Choroidal Neovascularization Drug
• 2.3 Manufacturing Process Analysis of Choroidal Neovascularization Drug
• 2.4 Industry Chain Structure of Choroidal Neovascularization Drug

3 Development and Manufacturing Plants Analysis of Choroidal Neovascularization Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Choroidal Neovascularization Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Choroidal Neovascularization Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Choroidal Neovascularization Drug Production and Capacity Analysis
• 4.2 Choroidal Neovascularization Drug Revenue Analysis
• 4.3 Choroidal Neovascularization Drug Price Analysis
• 4.4 Market Concentration Degree

5 Choroidal Neovascularization Drug Regional Market Analysis

• 5.1 Choroidal Neovascularization Drug Production by Regions
  • 5.1.1 Global Choroidal Neovascularization Drug Production by Regions
  • 5.1.2 Global Choroidal Neovascularization Drug Revenue by Regions
• 5.2 Choroidal Neovascularization Drug Consumption by Regions
• 5.3 North America Choroidal Neovascularization Drug Market Analysis
  • 5.3.1 North America Choroidal Neovascularization Drug Production
  • 5.3.2 North America Choroidal Neovascularization Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Choroidal Neovascularization Drug Import and Export
• 5.4 Europe Choroidal Neovascularization Drug Market Analysis
  • 5.4.1 Europe Choroidal Neovascularization Drug Production
  • 5.4.2 Europe Choroidal Neovascularization Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Choroidal Neovascularization Drug Import and Export
• 5.5 China Choroidal Neovascularization Drug Market Analysis
  • 5.5.1 China Choroidal Neovascularization Drug Production
  • 5.5.2 China Choroidal Neovascularization Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Choroidal Neovascularization Drug Import and Export
• 5.6 Japan Choroidal Neovascularization Drug Market Analysis
  • 5.6.1 Japan Choroidal Neovascularization Drug Production
  • 5.6.2 Japan Choroidal Neovascularization Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Choroidal Neovascularization Drug Import and Export
• 5.7 Southeast Asia Choroidal Neovascularization Drug Market Analysis
  • 5.7.1 Southeast Asia Choroidal Neovascularization Drug Production
  • 5.7.2 Southeast Asia Choroidal Neovascularization Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Choroidal Neovascularization Drug Import and Export
• 5.8 India Choroidal Neovascularization Drug Market Analysis
  • 5.8.1 India Choroidal Neovascularization Drug Production
  • 5.8.2 India Choroidal Neovascularization Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Choroidal Neovascularization Drug Import and Export

6 Choroidal Neovascularization Drug Segment Market Analysis (by Type)

• 6.1 Global Choroidal Neovascularization Drug Production by Type
• 6.2 Global Choroidal Neovascularization Drug Revenue by Type
• 6.3 Choroidal Neovascularization Drug Price by Type

7 Choroidal Neovascularization Drug Segment Market Analysis (by Application)

• 7.1 Global Choroidal Neovascularization Drug Consumption by Application
• 7.2 Global Choroidal Neovascularization Drug Consumption Market Share by Application (2014-2019)

8 Choroidal Neovascularization Drug Major Manufacturers Analysis

• 8.1 Cellphire, Inc.
  • 8.1.1 Cellphire, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
  • 8.1.2 Cellphire, Inc. Product Introduction, Application and Specification
  • 8.1.3 Cellphire, Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Chrysalis BioTherapeutics, Inc.
  • 8.2.1 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
  • 8.2.2 Chrysalis BioTherapeutics, Inc. Product Introduction, Application and Specification
  • 8.2.3 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Cleveland BioLabs, Inc.
  • 8.3.1 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
  • 8.3.2 Cleveland BioLabs, Inc. Product Introduction, Application and Specification
  • 8.3.3 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Cumberland Pharmaceuticals, Inc.
  • 8.4.1 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
  • 8.4.2 Cumberland Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.4.3 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Diffusion Pharmaceuticals Inc.
  • 8.5.1 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Production Sites and Area Served
  • 8.5.2 Diffusion Pharmaceuticals Inc. Product Introduction, Application and Specification
  • 8.5.3 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Eli Lilly and Company
  • 8.6.1 Eli Lilly and Company Choroidal Neovascularization Drug Production Sites and Area Served
  • 8.6.2 Eli Lilly and Company Product Introduction, Application and Specification
  • 8.6.3 Eli Lilly and Company Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 GNI Group Ltd.
  • 8.7.1 GNI Group Ltd. Choroidal Neovascularization Drug Production Sites and Area Served
  • 8.7.2 GNI Group Ltd. Product Introduction, Application and Specification
  • 8.7.3 GNI Group Ltd. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Humanetics Corporation
  • 8.8.1 Humanetics Corporation Choroidal Neovascularization Drug Production Sites and Area Served
  • 8.8.2 Humanetics Corporation Product Introduction, Application and Specification
  • 8.8.3 Humanetics Corporation Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 INSYS Therapeutics, Inc.
  • 8.9.1 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
  • 8.9.2 INSYS Therapeutics, Inc. Product Introduction, Application and Specification
  • 8.9.3 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Meabco A/S
  • 8.10.1 Meabco A/S Choroidal Neovascularization Drug Production Sites and Area Served
  • 8.10.2 Meabco A/S Product Introduction, Application and Specification
  • 8.10.3 Meabco A/S Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Neumedicines Inc.
• 8.12 Onconova Therapeutics, Inc.
• 8.13 PharmaIN Corporation
• 8.14 Pluristem Therapeutics Inc.
• 8.15 ProCertus BioPharm Inc.
• 8.16 RDD Pharma Ltd.
• 8.17 RedHill Biopharma Ltd.
• 8.18 RxBio, Inc.
• 8.19 Soligenix, Inc.

9 Development Trend of Analysis of Choroidal Neovascularization Drug Market

• 9.1 Global Choroidal Neovascularization Drug Market Trend Analysis
  • 9.1.1 Global Choroidal Neovascularization Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Choroidal Neovascularization Drug Regional Market Trend
  • 9.2.1 North America Choroidal Neovascularization Drug Forecast 2019-2025
  • 9.2.2 Europe Choroidal Neovascularization Drug Forecast 2019-2025
  • 9.2.3 China Choroidal Neovascularization Drug Forecast 2019-2025
  • 9.2.4 Japan Choroidal Neovascularization Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Choroidal Neovascularization Drug Forecast 2019-2025
  • 9.2.6 India Choroidal Neovascularization Drug Forecast 2019-2025
• 9.3 Choroidal Neovascularization Drug Market Trend (Product Type)
• 9.4 Choroidal Neovascularization Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Choroidal Neovascularization Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List